Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Graf

Showing results (301-310 of 318) with videos related to

Pageof 32
Sort By:
Cancer Cell|February 12, 2015
Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumorsJenny Wegert, Naveed Ishaque, Romina Vardapour, et al.
International Journal of Cancer|January 18, 2021
Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (SIOP) 93-01, 2001 and UK-IMPORT database: A report of the SIOP-Renal Tumor Study GroupJustine N van der Beek, Janna A Hol, Aurore Coulomb-l'Hermine, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 7, 2021
MRI Characteristics of Pediatric Renal Tumors: A SIOP-RTSG Radiology Panel Delphi StudyJustine N van der Beek, Tom A Watson, Rutger A J Nievelstein, et al.
JCO Oncology Practice|August 25, 2025
Assessing an eHealth Intervention on Quality of Life in Patients With Chronic Lymphocytic Leukemia and Myelodysplastic Syndromes: The MyPal Randomized Controlled TrialThomas Chatzikonstantinou, Maria Vasilopoulou, Dimitrios Kyrou, et al.
Cancer Discovery|December 12, 2024
Predisposition Footprints in the Somatic Genome of Wilms TumorsTaryn D Treger, Jenny Wegert, Anna Wenger, et al.
Nature Methods|September 6, 2011
Toward the blood-borne miRNome of human diseasesAndreas Keller, Petra Leidinger, Andrea Bauer, et al.
Neuro-Oncology|December 29, 2019
Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumorsMichael C Frühwald, Martin Hasselblatt, Karolina Nemes, et al.
Leukemia|August 22, 2019
Genotyping circulating tumor DNA of pediatric Hodgkin lymphomaAnn-Kathrin Desch, Kristin Hartung, Ante Botzen, et al.
NPJ Precision Oncology|December 27, 2022
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORMHeike Peterziel, Nora Jamaladdin, Dina ElHarouni, et al.
The Lancet. Oncology|June 27, 2024
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trialSelim Corbacioglu, Holger Lode, Susanne Ellinger, et al.
Pageof 32

Showing results (301-310 of 318) with videos related to

Sort By:
Pageof 32
Cancer Cell|February 12, 2015
Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumorsJenny Wegert, Naveed Ishaque, Romina Vardapour, et al.
International Journal of Cancer|January 18, 2021
Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (SIOP) 93-01, 2001 and UK-IMPORT database: A report of the SIOP-Renal Tumor Study GroupJustine N van der Beek, Janna A Hol, Aurore Coulomb-l'Hermine, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 7, 2021
MRI Characteristics of Pediatric Renal Tumors: A SIOP-RTSG Radiology Panel Delphi StudyJustine N van der Beek, Tom A Watson, Rutger A J Nievelstein, et al.
JCO Oncology Practice|August 25, 2025
Assessing an eHealth Intervention on Quality of Life in Patients With Chronic Lymphocytic Leukemia and Myelodysplastic Syndromes: The MyPal Randomized Controlled TrialThomas Chatzikonstantinou, Maria Vasilopoulou, Dimitrios Kyrou, et al.
Cancer Discovery|December 12, 2024
Predisposition Footprints in the Somatic Genome of Wilms TumorsTaryn D Treger, Jenny Wegert, Anna Wenger, et al.
Nature Methods|September 6, 2011
Toward the blood-borne miRNome of human diseasesAndreas Keller, Petra Leidinger, Andrea Bauer, et al.
Neuro-Oncology|December 29, 2019
Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumorsMichael C Frühwald, Martin Hasselblatt, Karolina Nemes, et al.
Leukemia|August 22, 2019
Genotyping circulating tumor DNA of pediatric Hodgkin lymphomaAnn-Kathrin Desch, Kristin Hartung, Ante Botzen, et al.
NPJ Precision Oncology|December 27, 2022
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORMHeike Peterziel, Nora Jamaladdin, Dina ElHarouni, et al.
The Lancet. Oncology|June 27, 2024
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trialSelim Corbacioglu, Holger Lode, Susanne Ellinger, et al.
Pageof 32